| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/14/2013 | CN101952320B Material with immunogenicity |
| 08/14/2013 | CN101942017B Tumor marker |
| 08/14/2013 | CN101927012B Virus inactivating method for nerve growth factors |
| 08/14/2013 | CN101918437B Polypeptides comprising an ice-binding activity |
| 08/14/2013 | CN101688210B Erythropoietin fusion protein |
| 08/14/2013 | CN101654475B Antigenic epitope of human tumor necrosis factor alpha and preparation method and application thereof |
| 08/14/2013 | CN101616929B Peptide-complement conjugates |
| 08/14/2013 | CN101591380B Bacterial insecticidal protein |
| 08/14/2013 | CN101490082B Method for producing insulin analogs having dibasic B chain terminus |
| 08/14/2013 | CN101415725B Peptide compound with biological activity, its preparation and its application |
| 08/14/2013 | CN101128478B N protein mutants of porcine reproductive and respiratory syndrome virus |
| 08/14/2013 | CN101010333B Purification of factor XIII polypeptides from biological materials |
| 08/13/2013 | US8507770 Variety corn line NPHD1001 |
| 08/13/2013 | US8507768 Inbred maize variety PH11T4 |
| 08/13/2013 | US8507753 Plants having enhanced yield-related traits and a method for making the same |
| 08/13/2013 | US8507659 Method for chemically modifying biopolymer and polypeptide |
| 08/13/2013 | US8507653 In vivo half life; reversible pegylation using such as carbamate connector; synthesis |
| 08/13/2013 | US8507646 Treating atherosclerosis |
| 08/13/2013 | US8507437 Apoptosis-modulating p53 protein therapy for vascular disorders and nanoparticles containing the same |
| 08/13/2013 | US8507435 Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof |
| 08/13/2013 | US8507433 Cardioprotective effects of GHRH agonists |
| 08/13/2013 | US8507430 Methods for administering FGF18 |
| 08/13/2013 | US8507426 Peptides and related molecules that bind to TALL-1 |
| 08/13/2013 | US8507277 Nonviral vectors for delivering polynucleotides |
| 08/13/2013 | US8507273 Gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7p15-21 and uses thereof |
| 08/13/2013 | US8507267 AAV4 vector and uses thereof |
| 08/13/2013 | US8507249 Bacterial virulence factors and uses thereof |
| 08/13/2013 | US8507245 Site-directed pegylation of arginases and the use thereof as anti-cancer and anti-viral agents |
| 08/13/2013 | US8507222 Multimeric IL-15 soluble fusion molecules and methods of making and using same |
| 08/13/2013 | US8507221 Process for the expression of peptides of interest using GCSF as a fusion partner |
| 08/13/2013 | US8507211 Tuberculosis diagnostic test |
| 08/13/2013 | US8507196 Nucleic acid probe of human immunodeficiency virus type 1 (HIV-1), and a method and kit employing this probe for detecting the presence of nucleic acid of HIV-1 |
| 08/13/2013 | US8506994 Use of the cathelicidin LL-37 and derivatives thereof for wound healing |
| 08/13/2013 | US8506958 Methods for treating TWEAK-related conditions |
| 08/13/2013 | US8506933 Methods of detecting a neurological condition via analysis of circulating phagocytes |
| 08/13/2013 | US8506407 Gaming system network and method for delivering gaming media |
| 08/13/2013 | US8506406 Network access device and method to run a game application |
| 08/13/2013 | CA2743539C Angiotensin-converting enzyme inhibitory peptides |
| 08/13/2013 | CA2709871C Polymer precursors of radiolabeled compounds, and methods of making and using the same |
| 08/13/2013 | CA2587092C A method of expressing small peptides using cereal non-storage proteins as fusion carrier in endosperm and the use thereof |
| 08/13/2013 | CA2569795C Process for the purification of il-18 binding protein |
| 08/13/2013 | CA2562784C Fluorocarbon antigen delivery vectors and constructs |
| 08/13/2013 | CA2544473C A recombinant protein having an anti-cancer effect, its encoding gene and uses thereof |
| 08/13/2013 | CA2543406C Mutants of human chondromodulin-i (hchm-i) and uses thereof in inhibiting angiogenesis and bone resorption |
| 08/13/2013 | CA2536354C Atopic dermatitis inducer |
| 08/13/2013 | CA2529647C Influenza hemagglutinin and neuraminidase variants |
| 08/13/2013 | CA2526891C Angiotensin-converting enzyme inhibitory peptides |
| 08/13/2013 | CA2517673C Improved vaccines for preventing viral infection |
| 08/13/2013 | CA2482930C Epha2 antigen t epitopes |
| 08/13/2013 | CA2469151C Immunocytokines with modulated selectivity |
| 08/13/2013 | CA2464138C Methods of preventing and treating flavivirus infection in animals |
| 08/13/2013 | CA2450020C Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using dna sequences |
| 08/13/2013 | CA2438513C Modified anti-egfr antibodies with reduced immunogenicity |
| 08/13/2013 | CA2433316C Molecular antigen array |
| 08/13/2013 | CA2413003C Immunoassays for anti-hcv antibodies |
| 08/13/2013 | CA2410224C Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 08/13/2013 | CA2371928C Neisserial vaccine compositions and methods |
| 08/13/2013 | CA2314319C Novel surface protein of neisseria meningitidis |
| 08/13/2013 | CA2304932C Recombinant rsv virus expression systems and vaccines |
| 08/13/2013 | CA2294648C Improved enterobacteriaceae fermentation strains |
| 08/13/2013 | CA2273847C Diagnosis of disease state using mrna profiles |
| 08/13/2013 | CA2258277C Characterization of granulocytic ehrlichia and methods of use |
| 08/13/2013 | CA2225377C Novel tgf-.beta. like cytokine |
| 08/08/2013 | WO2013116501A2 Sequence of 55 new found proteins and their application |
| 08/08/2013 | WO2013114363A2 Antimicrobial agents |
| 08/08/2013 | WO2013114165A1 Process of obtaining glycoprotein composition with increased afucosylation content |
| 08/08/2013 | WO2013113911A2 Nucleotide sequences involved in plant pest resistance |
| 08/08/2013 | WO2013113851A1 Muteins of a1m lipocalin and method of production therefor |
| 08/08/2013 | WO2013113774A1 Factor xii inhibitors for the treatment of neurological inflammatory disorders |
| 08/08/2013 | WO2013113755A1 Reagents and methods for the treatment of diseases based on the inhibition of calcineurin - nfat signalling pathway |
| 08/08/2013 | WO2013113622A1 Lipase variants and polynucleotides encoding same |
| 08/08/2013 | WO2013113370A1 Gpcr with improved cell surface expression |
| 08/08/2013 | WO2013113107A1 Methods for promoting neuron survival, axonal growth and/or regeneration |
| 08/08/2013 | WO2013113076A1 Modified epitopes for boosting cd4+ t-cell responses |
| 08/08/2013 | WO2013113060A1 Peptide |
| 08/08/2013 | WO2013098819A9 Isolated polynucleotides and polypeptides, and methods of using same for increasing yield of plants |
| 08/08/2013 | WO2013087601A3 Polyomavirus peptide sequences |
| 08/08/2013 | WO2013082298A3 Immunological composition for clostridium difficile |
| 08/08/2013 | WO2013073998A3 Novel derivatives of hemin with antibacterial and antiviral activity |
| 08/08/2013 | WO2013065017A3 Platelet rich plasma (prp) and prominin-1 derived peptides stimulate lymphangiogenesis |
| 08/08/2013 | WO2012175742A3 Methods for the production of a cosmetic composition comprising leukolectin and uses thereof |
| 08/08/2013 | WO2012128806A8 Methods and compositions comprising il-7 receptor ligands |
| 08/08/2013 | US20130205441 Chloroplast transit peptide |
| 08/08/2013 | US20130205440 Synthetic brassica-derived chloroplast transit peptides |
| 08/08/2013 | US20130204069 Compositions and Methods of Treating Tumors |
| 08/08/2013 | US20130203971 Method for purification of complement factor h |
| 08/08/2013 | US20130203961 Molecular Vaccine Linking an Endoplasmic Reticulum Chaperone Polypeptide to an Antigen |
| 08/08/2013 | US20130203959 Nonnatural collagen-like protein and use thereof |
| 08/08/2013 | US20130203805 Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase |
| 08/08/2013 | US20130203683 Immunoregulatory peptides and methods of use |
| 08/08/2013 | US20130203682 Rank ligand polypeptides |
| 08/08/2013 | US20130203679 Immunoregulatory peptides and methods of use |
| 08/08/2013 | US20130203676 Mu-conotoxin peptides and use thereof as a local anesthetic |
| 08/08/2013 | US20130203674 Process for production of bivalirudin |
| 08/08/2013 | US20130203673 Glucagon-like peptide-2 analogs |
| 08/08/2013 | US20130203672 Novel Glucagon Like Peptide Analogs, Composition, and Method of Use |
| 08/08/2013 | US20130203665 Single-chain insulin agonists exhibiting high activity at the insulin receptor |
| 08/08/2013 | US20130203661 Highly soluble leptins |
| 08/08/2013 | US20130203660 Glucagon/glp-1 receptor co-agonists |
| 08/08/2013 | US20130203659 Glp-1 compounds |